Skip to main content
. 2019 Jul 31;9(7):e030290. doi: 10.1136/bmjopen-2019-030290

Table 4.

Identified enablers and barriers to treatment adherence

Enablers Barriers
Other family members following treatment regime Mismatch between perceived and actual risk
Commencement of treatment from a young age Concerns over the use of lipid lowering medication
Parental responsibility to care for children Prioritisation of medication over lifestyle treatment
Confidence in ability to successfully self-manage their condition Lifestyle treatment is difficult to comply with
Receiving formal diagnosis of FH Prioritisation of other life events
Practical resources and support for following lifestyle treatment Inadequate and/or incorrect knowledge of treatment advice
A positive relationship with healthcare professional

FH, familial hypercholesterolaemia.